George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 486.00
Bid: 484.00
Ask: 488.00
Change: 16.00 (3.40%)
Spread: 4.00 (0.826%)
Open: 465.00
High: 486.00
Low: 465.00
Prev. Close: 470.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Executive Officer

4 Mar 2024 07:00

RNS Number : 3428F
Treatt PLC
04 March 2024
 

4 March 2024

 

TREATT PLC

 ("Treatt" or "the Group")

 

Appointment of Chief Executive Officer

 

 

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today announces the appointment of David Shannon as Group Chief Executive Officer and a Director effective on 3 June 2024.

 

David joins Treatt from Croda International Plc where he has held a number of senior roles, recently as President of Consumer Care and an Executive Committee member. He has extensive experience in selling specialty ingredients in the B2B environment for the Flavour and Fragrance, Personal Care, Pharmaceutical and Agricultural industries worldwide.

 

David has a proven track record of sustainably growing businesses in dynamic markets. He has spent 13 years in various roles in the USA, a key market for Treatt, and has recently overseen a new manufacturing project in China. David's experience includes global business management, setting and delivering strategy, optimising science and innovation to drive revenue growth, identifying new ways to maximise revenue and attracting, retaining and developing employees. He has a degree in Chemistry from Edinburgh University.

 

Ryan Govender and Alison Sleight will continue as Interim CEO & Interim CFO respectively until David joins, when Ryan will resume as CFO and Alison as Group Finance & IT Director, and the Board thanks them for their continued commitment and strong contribution.

 

Vijay Thakrar, Chair of Treatt, commented:

 

"Following a robust search process that attracted a number of high quality candidates, we are thrilled that David is joining the Treatt team. He has highly relevant international experience delivering growth in an innovation led group, with a motivational and collaborative leadership style, which will enable him to lead Treatt through its next, exciting phase. The Board and I look forward to working closely with David, Ryan and our Leadership Team as they focus on realising the full potential of Treatt following the investments of recent years.

 

David Shannon added:

 

"I am honoured to be joining Treatt as CEO, a company that has a remarkable history of delivering excellence to its customers through sustainability, innovation and agility, supported by a unique culture. I am looking forward to working with everyone at Treatt to build on its strong foundation, unlock new opportunities and chart a path of sustained success."

 

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13 in relation to the appointment.

 

 

 

Treatt plc +44 (0)1284 702500

Vijay Thakrar Chair

Ryan Govender ? Interim Chief Executive Officer

Alison Sleight Interim Chief Financial Officer

 

Brokers

Investec Bank plc +44 (0) 20 7597 5970

Patrick Robb

David Anderson

 

Peel Hunt LLP +44 (0) 20 7418 8900

George Sellar

Mike Burke

 

Financial PR

MHP Communications +44 (0) 20 3128 8789

Tim Rowntree

Eleni Menikou

Catherine Chapman

 

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 350 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

For further information about the Group, visit www.treatt.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUUPWUPCGMG
Date   Source Headline
10th Apr 20247:00 amRNSHalf Year Trading Update & Notice of Results
19th Mar 20243:40 pmRNSNotification of Transactions of Directors
4th Mar 20247:00 amRNSAppointment of Chief Executive Officer
13th Feb 20249:35 amRNSHolding(s) in Company
31st Jan 20242:41 pmRNSNotification of Transaction of PDMR
25th Jan 20243:49 pmRNSResult of AGM
25th Jan 20247:00 amRNSAGM Trading Update
23rd Jan 20241:57 pmRNSTotal Voting Rights
21st Dec 20232:07 pmRNSNotification of Transaction of Director
15th Dec 20236:09 pmRNSNotification of Transactions - Replacement
15th Dec 20234:42 pmRNSNotification of Transactions of Directors
13th Dec 20237:00 amRNSInterim Chief Financial Officer Appointment
12th Dec 20234:24 pmRNSAnnual Report and Notice of Annual General Meeting
1st Dec 20237:01 amRNSBlock Listing Six Monthly Return
1st Dec 20237:00 amRNSBlock Listing Six Monthly Return
28th Nov 20234:15 pmRNS2023 Final Dividend
28th Nov 20237:00 amRNSFull Year Results
20th Oct 20237:00 amRNSCEO Succession
10th Oct 20237:00 amRNSTrading Update
18th Sep 20234:11 pmRNSHolding(s) in Company
15th Aug 20234:14 pmRNSNotification of Transactions of Directors
28th Jul 202310:43 amRNSTotal Voting Rights
13th Jul 202312:15 pmRNSReplacement - Director/PDMR Shareholding
13th Jul 202311:09 amRNSNotification of Transaction of Director
21st Jun 20234:05 pmRNSNotification of Transactions of Director
12th Jun 20234:13 pmRNSDirector Declaration
7th Jun 20232:28 pmRNSBlock Listing Application
1st Jun 20237:00 amRNSBlock listing Six Monthly Return
19th May 20235:10 pmRNSHolding(s) in Company
19th May 20234:28 pmRNSHolding(s) in Company
9th May 20237:00 amRNSHalf Year Results
12th Apr 20237:00 amRNSHalf Year Trading Update and Notice of Results
20th Mar 20233:28 pmRNSNotification of Transactions of Directors
7th Mar 20233:25 pmRNSDirector/PDMR Shareholding
22nd Feb 20233:06 pmRNSHolding(s) in Company
21st Feb 202312:51 pmRNSNotification of Transactions of Director
21st Feb 202312:49 pmRNSNotification of Transactions of Director
20th Feb 202311:01 amRNSNotification of Transaction of a Director
30th Jan 20231:49 pmRNSHolding(s) in Company
27th Jan 20233:10 pmRNSResult of AGM
27th Jan 20237:00 amRNSAGM Trading Update
10th Jan 20235:05 pmRNSVoting Rights and Capital
28th Dec 20227:00 amRNSNotification of Transaction of Director
28th Dec 20227:00 amRNSAnnual Report and Notice of Annual General Meeting
20th Dec 202212:20 pmRNSBoard Appointment and Board Committee Changes
16th Dec 20221:25 pmRNSNotification of Transactions of Directors
1st Dec 20223:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20223:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Nov 20224:36 pmRNSPrice Monitoring Extension
29th Nov 20227:10 amRNSFull Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.